SEC Form 4 · accession 0001179110-17-003202
MOMENTA PHARMACEUTICALS INC · MNTA
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Ganesh Venkataraman Kaundinya
Officer — Senior V.P., Research
Period of report
Feb 22, 2017
Accepted (ET)
Feb 24, 2017 · 6:24 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001235010
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Feb 22, 2017 | S | 231 | $15.60 | D | 491,675 | D | |
| Common Stock | Feb 22, 2017 | S | 404 | $15.60 | D | 491,271 | D | |
| Common Stock | Feb 22, 2017 | S | 434 | $15.60 | D | 490,837 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on January 25, 2009.